GlassVC
Matthew Roden

Matthew Roden

Entrepreneur Partner · MPM BioImpact

Venture Partner

Dr. Matthew Roden is an Entrepreneur Partner at MPM BioImpact and CEO of portfolio company Aktis Oncology. His career spans senior leadership in large pharma, healthcare equity capital markets and basic science, most recently as Senior Vice President and Head of Enterprise Strategy at Bristol Myers Squibb.

Board seats

10 current

· PUBLIC SOURCES

Credited hits

1

· PUBLIC SOURCES

Midas years

No public record

LAST CHECKED NOV 2026

Founder rating

No public record

LAST CHECKED NOV 2026

Maintained from public sources. Not claimed. If you're Matthew Roden, you can claim this profile.

Claim this profileHow claiming works

Claiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.

Track record

Credited deals only — Matthew Roden is named in a public source as investor, lead, or board member on these deals. This is not a complete investment history, and absence here is not evidence of absence.
  • Orna Therapeuticsacquired

    Acquired by Eli Lilly, per MPM BioImpact team page; Roden previously served on its board.

    Source: mpmbioimpact.com

Board seats

Current board seats · 0

Former board seats · 1

Success signals

Forbes Midas List

No public record

Not listed.

Reputation

No reputation score — basis not established for this investor.

No reputation sources on file yet.

Suggest a source

Contact

Published sources only

Published contact details collected from public sources. Not a referral, and not an introduction.

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

Claimed profiles can replace or remove contact details.

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Matthew Roden. Reviews come from founders whose identity and relationship have been verified.

Write the first review
Reviews of MPM BioImpact (0) →

Firm-level reviews are not attributed to Matthew Roden.

Methodology

This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.

Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.

Corrections with a source: Suggest a correction.

Source record 1

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Matthew Roden — provenance: GlassVC catalog

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: Title · Firm · Type · Bio · Location · Credited deals · Board seats

EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026